Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels - PubMed (original) (raw)
. 2001 Aug 17;276(33):30701-7.
doi: 10.1074/jbc.M102849200. Epub 2001 Jun 11.
Affiliations
- PMID: 11402035
- DOI: 10.1074/jbc.M102849200
Free article
Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels
F Kirschenbaum et al. J Biol Chem. 2001.
Free article
Abstract
The majority of familial Alzheimer's disease cases have been attributed to mutations in the presenilin 1 (PS1) gene. PS1 is synthesized as an inactive holoprotein that undergoes endoproteolytic processing to generate a functional N- and C-terminal heterodimer (NTF and CTF, respectively). We identified a single residue in PS1, Ser(397), which regulates the CTF levels in a population of dimer that has a rapid turnover. This residue is part of a highly conserved glycogen synthase kinase-3beta (GSK-3beta) consensus phosphorylation site within the loop domain of PS1. Site-directed mutagenesis at the Ser(397) position increased levels of PS1 CTF but not NTF or holoprotein. Similar increases in only CTF levels were seen when cells expressing wild type PS1 were treated with lithium chloride, an inhibitor of GSK-3beta. Both wild type and PS1 S397A CTF displayed a biphasic turnover, reflecting rapidly degraded and stable populations. Rapid turnover was delayed for mutant PS1 S397A, causing increased CTF. These data demonstrate that PS1 NTF.CTF endoproteolytic fragments are generated in excess, that phosphorylation at Ser(397) by GSK-3beta regulates the discard of excess CTF, and that the disposal of surplus NTF is mediated by an independent mechanism. Overall, the results indicate that production of active NTF.CTF dimer is more complex than limited endoproteolysis of PS1 holoprotein and instead involves additional regulatory events.
Similar articles
- Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling.
Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV. Kirschenbaum F, et al. J Biol Chem. 2001 Mar 9;276(10):7366-75. doi: 10.1074/jbc.M004697200. Epub 2000 Dec 4. J Biol Chem. 2001. PMID: 11104755 - PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling.
Levitan D, Lee J, Song L, Manning R, Wong G, Parker E, Zhang L. Levitan D, et al. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12186-90. doi: 10.1073/pnas.211321898. Epub 2001 Oct 2. Proc Natl Acad Sci U S A. 2001. PMID: 11593035 Free PMC article. - Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion.
Palacino JJ, Murphy MP, Murayama O, Iwasaki K, Fujiwara M, Takashima A, Golde TE, Wolozin B. Palacino JJ, et al. J Biol Chem. 2001 Oct 19;276(42):38563-9. doi: 10.1074/jbc.M105376200. Epub 2001 Aug 14. J Biol Chem. 2001. PMID: 11504726 - Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau.
Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, Nihonmatsu N, Mercken M, Yamaguchi H, Sugihara S, Wolozin B. Takashima A, et al. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9637-41. doi: 10.1073/pnas.95.16.9637. Proc Natl Acad Sci U S A. 1998. PMID: 9689133 Free PMC article. - Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate.
Twomey C, McCarthy JV. Twomey C, et al. FEBS Lett. 2006 Jul 24;580(17):4015-20. doi: 10.1016/j.febslet.2006.06.035. Epub 2006 Jun 22. FEBS Lett. 2006. PMID: 16814287
Cited by
- The role of GSK-3 in synaptic plasticity.
Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, Wang YT, Collingridge GL. Peineau S, et al. Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S428-37. doi: 10.1038/bjp.2008.2. Br J Pharmacol. 2008. PMID: 18311157 Free PMC article. Review. - NSE-controlled carboxyl-terminus of APP gene over-expressing in transgenic mice induces altered expressions in behavior, Abeta-42, and GSK3beta binding proteins.
Lim HJ, Cho JS, Oh JH, Shim SB, Hwang DY, Jee SW, Lee SH, Sheen YY, Lee SH, Kim YK. Lim HJ, et al. Cell Mol Neurobiol. 2005 Aug;25(5):833-50. doi: 10.1007/s10571-005-4937-7. Cell Mol Neurobiol. 2005. PMID: 16133937 Free PMC article. - Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.
Jope RS, Yuskaitis CJ, Beurel E. Jope RS, et al. Neurochem Res. 2007 Apr-May;32(4-5):577-95. doi: 10.1007/s11064-006-9128-5. Epub 2006 Aug 30. Neurochem Res. 2007. PMID: 16944320 Free PMC article. Review. - GSK-3 in Neurodegenerative Diseases.
Lei P, Ayton S, Bush AI, Adlard PA. Lei P, et al. Int J Alzheimers Dis. 2011;2011:189246. doi: 10.4061/2011/189246. Epub 2011 May 4. Int J Alzheimers Dis. 2011. PMID: 21629738 Free PMC article. - Candesartan Restores the Amyloid Beta-Inhibited Proliferation of Neural Stem Cells by Activating the Phosphatidylinositol 3-Kinase Pathway.
Choi H, Choi NY, Lee KY, Lee YJ, Koh SH. Choi H, et al. Dement Neurocogn Disord. 2017 Sep;16(3):64-71. doi: 10.12779/dnd.2017.16.3.64. Epub 2017 Sep 30. Dement Neurocogn Disord. 2017. PMID: 30906373 Free PMC article.